Michael Doligalski

Michael Doligalski began their work experience in 2007 as a Research Associate and Peptide Chemist at Affinergy. Michael then moved to the University of South Florida, where they served as an Interdisciplinary NMR Facility Graduate Assistant. In 2015, they joined the H. Lee Moffitt Cancer Center and Research Institute as a Research Associate and later as a Postdoctoral Fellow. From 2017 to 2021, Michael worked at Parion Sciences as an Associate Scientist, focusing on analytical and bioanalytical measurements. Currently, they are at Aktis Oncology as a Senior Scientist and recently transitioned to the role of Principal Scientist and Head of DMPK in October 2022. Throughout their career, they have showcased expertise in research, analytical development, and leadership in the pharmaceutical industry.

Michael Doligalski completed their Bachelor's Degree in Chemistry with a concentration in biological chemistry from the University of North Carolina at Chapel Hill in 2007. Michael went on to further their education by obtaining a PhD in Organic Chemistry from the University of South Florida, graduating in 2016.